146 related articles for article (PubMed ID: 11139453)
1. Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2000 Dec; 131(8):1732-8. PubMed ID: 11139453
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
3. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
Bunting MW; Widdop RE
Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
[TBL] [Abstract][Full Text] [Related]
4. Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2001 Aug; 133(8):1371-7. PubMed ID: 11498524
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670.
Douglas SA; Gellai M; Ezekiel M; Feuerstein GZ; Elliott JD; Ohlstein EH
Hypertension; 1995 Apr; 25(4 Pt 2):818-22. PubMed ID: 7721437
[TBL] [Abstract][Full Text] [Related]
6. Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic ((mRen-2)27) rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1998 Apr; 123(7):1403-8. PubMed ID: 9579736
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
[TBL] [Abstract][Full Text] [Related]
8. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
9. Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(1):141-9. PubMed ID: 8733587
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelin in hypertension of experimental chronic renal failure.
Potter GS; Johnson RJ; Fink GD
Hypertension; 1997 Dec; 30(6):1578-84. PubMed ID: 9403586
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
12. Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat.
Barone FC; Ohlstein EH; Hunter AJ; Campbell CA; Hadingham SH; Parsons AA; Yang Y; Shohami E
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S357-61. PubMed ID: 11078420
[TBL] [Abstract][Full Text] [Related]
13. Injection of endothelin-1 into the raphe obscurus of rats induces depressor responses predominantly through endothelin ET(A) receptors.
D'Amico M; Di Filippo C; Esposito F; Rossi F; Filippelli A
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):471-6. PubMed ID: 10431758
[TBL] [Abstract][Full Text] [Related]
14. Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
Raval P; Bingham S; Aiyar N; Elliott JD; Hunter AJ; Ohlstein EH; Parsons AA
Br J Pharmacol; 1999 Jan; 126(2):485-93. PubMed ID: 10077242
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
17. Role for endothelin-1 in angiotensin II-mediated hypertension.
Rajagopalan S; Laursen JB; Borthayre A; Kurz S; Keiser J; Haleen S; Giaid A; Harrison DG
Hypertension; 1997 Jul; 30(1 Pt 1):29-34. PubMed ID: 9231817
[TBL] [Abstract][Full Text] [Related]
18. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1999 Dec; 128(8):1795-803. PubMed ID: 10588936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
